Cargando…

Clinicopathological characteristics of IgG4-related lung disease

BACKGROUND: Immunoglobulin G4-related lung disease (IgG4-RLD) is a rare entity. We retrospectively analyzed the clinical and histopathological characteristics of patients with pathologically confirmed IgG4-RLD to improve the diagnosis rate and reduce the risk of misdiagnosis. METHODS: We screened th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Liu, Yuxiang, Shen, Ximing, He, Zhanghai, Yu, Tingfeng, Pang, Li, Jin, Xiaoyan, Wang, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672518/
https://www.ncbi.nlm.nih.gov/pubmed/34911521
http://dx.doi.org/10.1186/s12890-021-01781-3
_version_ 1784615370487758848
author Liu, Jia
Liu, Yuxiang
Shen, Ximing
He, Zhanghai
Yu, Tingfeng
Pang, Li
Jin, Xiaoyan
Wang, Lingyun
author_facet Liu, Jia
Liu, Yuxiang
Shen, Ximing
He, Zhanghai
Yu, Tingfeng
Pang, Li
Jin, Xiaoyan
Wang, Lingyun
author_sort Liu, Jia
collection PubMed
description BACKGROUND: Immunoglobulin G4-related lung disease (IgG4-RLD) is a rare entity. We retrospectively analyzed the clinical and histopathological characteristics of patients with pathologically confirmed IgG4-RLD to improve the diagnosis rate and reduce the risk of misdiagnosis. METHODS: We screened the pathological reports of 4838 patients with pulmonary surgery and/or biopsy specimens from April 2017 to April 2021 at Sun Yat-Sen Memorial Hospital affiliated with Sun Yat-Sen University, and specimens from 65 patients with suspected IgG4-RLD were subjected to immunohistochemical staining for IgG4 and IgG. Finally, 10 patients with definite IgG4-RLD that was pathologically confirmed were enrolled and analyzed. RESULTS: The incidence of pathologically confirmed IgG4-RLD was 0.2% (10/4838). The ten patients had an average age of 59.7 years at diagnosis, and the male-to-female ratio was 9:1. The initial clinical manifestations were nonspecific, and cough was the most common symptom (4/10). More than one organ was involved in most patients (8/10), and mediastinal/hilar lymph node involvement was often observed (7/10). Serum IgG4 was analyzed in 6 patients and found to be elevated. Serum tumor marker levels were within the normal range or were slightly elevated. Computed tomography (CT) of the chest and/or (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) imaging revealed that 5 patients had a mixed type, 3 patients had the solid nodular type, and 2 patients had the bronchovascular type. All pulmonary masses and large nodules with solid patterns had spiculated margins and inhomogeneous enhancement with or without pleural indentation and a lobulated appearance. Abundant lymphoplasmacytic cell infiltration and fibrosis were observed in all patients. The expression of IgG4 and IgG was upregulated in the pulmonary sections. Seven patients were treated with glucocorticoids with or without additional immunosuppressants and responded well. CONCLUSIONS: The results of our study suggest that multiple imaging findings, an elevated serum IgG4 concentration, and no significant increase in serum tumor biomarkers could provide diagnostic support for IgG4-RLD, especially for isolated IgG4-RLD or IgG4-RLD that includes other organ involvement that does not aid in establishing the diagnosis.
format Online
Article
Text
id pubmed-8672518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86725182021-12-15 Clinicopathological characteristics of IgG4-related lung disease Liu, Jia Liu, Yuxiang Shen, Ximing He, Zhanghai Yu, Tingfeng Pang, Li Jin, Xiaoyan Wang, Lingyun BMC Pulm Med Research BACKGROUND: Immunoglobulin G4-related lung disease (IgG4-RLD) is a rare entity. We retrospectively analyzed the clinical and histopathological characteristics of patients with pathologically confirmed IgG4-RLD to improve the diagnosis rate and reduce the risk of misdiagnosis. METHODS: We screened the pathological reports of 4838 patients with pulmonary surgery and/or biopsy specimens from April 2017 to April 2021 at Sun Yat-Sen Memorial Hospital affiliated with Sun Yat-Sen University, and specimens from 65 patients with suspected IgG4-RLD were subjected to immunohistochemical staining for IgG4 and IgG. Finally, 10 patients with definite IgG4-RLD that was pathologically confirmed were enrolled and analyzed. RESULTS: The incidence of pathologically confirmed IgG4-RLD was 0.2% (10/4838). The ten patients had an average age of 59.7 years at diagnosis, and the male-to-female ratio was 9:1. The initial clinical manifestations were nonspecific, and cough was the most common symptom (4/10). More than one organ was involved in most patients (8/10), and mediastinal/hilar lymph node involvement was often observed (7/10). Serum IgG4 was analyzed in 6 patients and found to be elevated. Serum tumor marker levels were within the normal range or were slightly elevated. Computed tomography (CT) of the chest and/or (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) imaging revealed that 5 patients had a mixed type, 3 patients had the solid nodular type, and 2 patients had the bronchovascular type. All pulmonary masses and large nodules with solid patterns had spiculated margins and inhomogeneous enhancement with or without pleural indentation and a lobulated appearance. Abundant lymphoplasmacytic cell infiltration and fibrosis were observed in all patients. The expression of IgG4 and IgG was upregulated in the pulmonary sections. Seven patients were treated with glucocorticoids with or without additional immunosuppressants and responded well. CONCLUSIONS: The results of our study suggest that multiple imaging findings, an elevated serum IgG4 concentration, and no significant increase in serum tumor biomarkers could provide diagnostic support for IgG4-RLD, especially for isolated IgG4-RLD or IgG4-RLD that includes other organ involvement that does not aid in establishing the diagnosis. BioMed Central 2021-12-15 /pmc/articles/PMC8672518/ /pubmed/34911521 http://dx.doi.org/10.1186/s12890-021-01781-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Jia
Liu, Yuxiang
Shen, Ximing
He, Zhanghai
Yu, Tingfeng
Pang, Li
Jin, Xiaoyan
Wang, Lingyun
Clinicopathological characteristics of IgG4-related lung disease
title Clinicopathological characteristics of IgG4-related lung disease
title_full Clinicopathological characteristics of IgG4-related lung disease
title_fullStr Clinicopathological characteristics of IgG4-related lung disease
title_full_unstemmed Clinicopathological characteristics of IgG4-related lung disease
title_short Clinicopathological characteristics of IgG4-related lung disease
title_sort clinicopathological characteristics of igg4-related lung disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672518/
https://www.ncbi.nlm.nih.gov/pubmed/34911521
http://dx.doi.org/10.1186/s12890-021-01781-3
work_keys_str_mv AT liujia clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT liuyuxiang clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT shenximing clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT hezhanghai clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT yutingfeng clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT pangli clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT jinxiaoyan clinicopathologicalcharacteristicsofigg4relatedlungdisease
AT wanglingyun clinicopathologicalcharacteristicsofigg4relatedlungdisease